Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>3M Company reported strong second-quarter results marked by organic sales growth of 5.4%, operating margin expansion of 40 basis points to 24.9%, and 11% growth in adjusted earnings per share to $2.40.</li><li>Free cash flow reached $1.3 billion, with a conversion rate exceeding 100%, underscoring effective earnings quality and working capital management.</li><li>The company returned $1.4 billion to shareholders during the quarter through dividends and share repurchases and reaffirmed its commitment to returning over $10 billion to shareholders by 2027.</li></ul>

3M Company reported strong second-quarter results marked by organic sales growth of 5.4%, operating margin expansion of 40 basis points to 24.9%, and 11% growth in adjusted earnings per share to $2.40.Free cash flow reached $1.3 billion, with a conversion rate exceeding 100%, underscoring effective earnings quality and working capital management.The company returned $1.4 billion to shareholders during the quarter through dividends and share repurchases and reaffirmed its commitment to returning over $10 billion to shareholders by 2027.

3M Company’s 92-Product Innovation Surge: Could 350+ Launches Reshape Growth?

Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

Pan-Asia Catalysts/Events

Quiddity Advisors

Index Rebalance

<ul>
<li>The S&amp;P 500 index tracks the 500 largest names listed in the US and it is one of the most highly-tracked indices in the world.</li>
<li>The index is reviewed quarterly. The next review will be in June 2024 and the evaluation date for the rankings for the constituent selection process is 6th June 2024.</li>
<li>In this insight, we take a look at the Potential ADDs and Potential DELs for the June 2024 index rebal event and the intra-review ADDs/DELETEs.</li>
</ul>


The S&amp;P 500 index tracks the 500 largest names listed in the US and it is one of the most highly-tracked indices in the world.
The index is reviewed quarterly. The next review will be in June 2024 and the evaluation date for the rankings for the constituent selection process is 6th June 2024.
In this insight, we take a look at the Potential ADDs and Potential DELs for the June 2024 index rebal event and the intra-review ADDs/DELETEs.


Quiddity Leaderboard S&P 500 Jun 24 Rebal: Many Intra-Review Changes Possible Due to M&A, Spin-Offs

<ul><li>The company’s second quarter financial results for 2026 demonstrated a combination of organic growth, margin expansion, and improved earnings, reflecting ongoing progress against its strategic transformation priorities.</li><li>Organic sales increased by 5.4%, driven mainly by commercial excellence efforts, an accelerated pace of new product introductions, and sustained demand in core industrial markets.</li><li>This growth was broad-based geographically, with notable double-digit growth in China and India, mid-single-digit improvements in North America and Europe, and strong performance across safety, industrial, transport, and electronics segments.</li></ul>

The company’s second quarter financial results for 2026 demonstrated a combination of organic growth, margin expansion, and improved earnings, reflecting ongoing progress against its strategic transformation priorities.Organic sales increased by 5.4%, driven mainly by commercial excellence efforts, an accelerated pace of new product introductions, and sustained demand in core industrial markets.This growth was broad-based geographically, with notable double-digit growth in China and India, mid-single-digit improvements in North America and Europe, and strong performance across safety, industrial, transport, and electronics segments.

3M Launches 92 New Products — Its Fastest Innovation Push Since 2023!

<ul><li>The first quarter results of 3M Company showed a mixed but generally steady operational performance amidst a challenging macroeconomic landscape marked by pockets of softness in certain end markets.</li><li>The company reported earnings per share of $2.14, representing mid-teens growth year-over-year, alongside a modest 30 basis points expansion in operating margin to 23.8%.</li><li>Free cash flow exceeded $500 million, marking double-digit growth, supported by disciplined cost management, productivity improvements, and strong commercial execution.</li></ul>

The first quarter results of 3M Company showed a mixed but generally steady operational performance amidst a challenging macroeconomic landscape marked by pockets of softness in certain end markets.The company reported earnings per share of $2.14, representing mid-teens growth year-over-year, alongside a modest 30 basis points expansion in operating margin to 23.8%.Free cash flow exceeded $500 million, marking double-digit growth, supported by disciplined cost management, productivity improvements, and strong commercial execution.

3M Company: What Matters Now Is 35% Backlog Growth Momentum!

Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

<ul>
 <li>
Strategic Repositioning for Focused Growth: 3M is undergoing a significant transformation, highlighted by the spin-off of its healthcare business, Solventum, and a major restructuring program. This allows for a sharpened focus on its core industrial and consumer markets, with a strategy centered on innovation, operational efficiency, and disciplined capital allocation to drive future growth.</li>
 <li>
Innovation as a Core Competency: With a deep-rooted history in material science and a robust patent portfolio, 3M's commitment to research and development remains a key competitive advantage. The company plans to launch over 1,000 new products between 2025 and 2027, targeting high-growth sectors to fuel its innovation pipeline.</li>
 <li>
Navigating Significant Legal Headwinds: 3M faces substantial financial and reputational risks from extensive litigation related to its Combat Arms earplugs and PFAS 'forever chemicals.' While significant settlements have been reached, the ongoing legal challenges and potential for further liabilities remain a key concern for investors.</li>
</ul>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


  
Strategic Repositioning for Focused Growth: 3M is undergoing a significant transformation, highlighted by the spin-off of its healthcare business, Solventum, and a major restructuring program. This allows for a sharpened focus on its core industrial and consumer markets, with a strategy centered on innovation, operational efficiency, and disciplined capital allocation to drive future growth.
  
Innovation as a Core Competency: With a deep-rooted history in material science and a robust patent portfolio, 3M's commitment to research and development remains a key competitive advantage. The company plans to launch over 1,000 new products between 2025 and 2027, targeting high-growth sectors to fuel its innovation pipeline.
  
Navigating Significant Legal Headwinds: 3M faces substantial financial and reputational risks from extensive litigation related to its Combat Arms earplugs and PFAS 'forever chemicals.' While significant settlements have been reached, the ongoing legal challenges and potential for further liabilities remain a key concern for investors.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

United States

3M Co. conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets.  The Company's businesses share technologies, manufacturing operations, brands, marketing channels, and other resources.  3M serves customers in countries located around the world.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

3M Co (MMM US)

3M Company’s 92-Product Innovation Surge: Could 350+ Launches Reshape Growth?

3M Company reported strong second-quarter results marked by organic sales growth of 5.4%, operating margin expansion of 40 basis points to 24.9%,...

Baptista Research

Quiddity Leaderboard S&P 500 Jun 24 Rebal: Many Intra-Review Changes Possible Due to M&A, Spin-Offs

The SP500 will to see up to 4 intra-review changes before the June 2024 rebal. 3 near certain. The interesting ones? Two SP600 deletions due to...

Travis Lundy

3M Launches 92 New Products — Its Fastest Innovation Push Since 2023!

The company’s second quarter financial results for 2026 demonstrated a combination of organic growth, margin expansion, and improved earnings,...

Baptista Research

3M Company: What Matters Now Is 35% Backlog Growth Momentum!

The first quarter results of 3M Company showed a mixed but generally steady operational performance amidst a challenging macroeconomic landscape...

Baptista Research

Primer: 3M Co (MMM US) - Apr 2026

Strategic Repositioning for Focused Growth: 3M is undergoing a significant transformation, highlighted by the spin-off of its healthcare...

αSK Primers

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)